Anticancer Treatments and Cardiotoxicity

Produk Detail:
  • Author : Patrizio Lancellotti
  • Publisher : Academic Press
  • Pages : 470 pages
  • ISBN : 0128026472
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Anticancer Treatments and Cardiotoxicity

Download or Read online Anticancer Treatments and Cardiotoxicity full in PDF, ePub and kindle. this book written by Patrizio Lancellotti and published by Academic Press which was released on 11 November 2016 with total page 470 pages. We cannot guarantee that Anticancer Treatments and Cardiotoxicity book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality in cancer survivors and is one of the most common post-treatment issues among survivors of adult cancer. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is essential in the fight to decrease cardiotoxic mortality. This illustrated reference describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment. In addition, new guidelines on imaging for the screening and monitoring of these patients are also presented. Anticancer Treatments and Cardiotoxicity is an essential reference for those involved in the research and treatment of cardiovascular toxicity. Provides algorithms essential for the use of imaging, and biomarkers for the screening and monitoring of patients Written by world-leading experts in the field of cardiotoxicity Includes high-quality images, case studies, and test questions Describes the most effective diagnostic and imaging tools to evaluate and predict the development of cardiac dysfunction for those patients undergoing cancer treatment

Anticancer Treatments and Cardiotoxicity

Anticancer Treatments and Cardiotoxicity
  • Author : Patrizio Lancellotti,Jose L Zamorano,Maurizio Galderisi
  • Publisher : Academic Press
  • Release : 11 November 2016
GET THIS BOOK Anticancer Treatments and Cardiotoxicity

Anticancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions presents cutting edge research on the adverse cardiac effects of both radiotherapy and chemotherapy, brought together by leaders in the field. Cancer treatment-related cardiotoxicity is the leading cause of treatment-associated mortality in cancer survivors and is one of the most common post-treatment issues among survivors of adult cancer. Early detection of the patients prone to developing cardiotoxicity, taking in to account the type of treatment, history and other risk factors, is

Cardiac Management of Oncology Patients

Cardiac Management of Oncology Patients
  • Author : Gonzalo Baron Esquivias,Riccardo Asteggiano
  • Publisher : Springer
  • Release : 25 May 2015
GET THIS BOOK Cardiac Management of Oncology Patients

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in

Cardiotoxicity of Novel Cancer Therapies

Cardiotoxicity of Novel Cancer Therapies
  • Author : Edith Pituskin
  • Publisher : Unknown
  • Release : 20 September 2021
GET THIS BOOK Cardiotoxicity of Novel Cancer Therapies

Breast cancer is the most common malignancy among females, and the second leading cause of cancer death among Canadian women. Despite improved survival, both short and long term detrimental effects have been observed with both novel and conventional anti-cancer therapies. In particular, the effects of cancer therapy on the cardiovascular system, or 'cardiotoxicity', are increasingly recognized in terms of morbidity and mortality. Subtle or 'sub-clinical' early effects of anti-cancer therapies on cardiac structures may remain undetected, conveying potentially devastating longer-term

Manual of Cardio oncology

Manual of Cardio oncology
  • Author : Chiara Lestuzzi,Stefano Oliva,Francesco Ferraù
  • Publisher : Springer
  • Release : 13 October 2017
GET THIS BOOK Manual of Cardio oncology

This concise and handy manual provides straightforward, up-to-date guidance for cardiologists and other practitioners on the management of cancer patients with cardiac problems, whether they be due to the cancer itself or to antineoplastic treatment. Detailed attention is devoted to the various forms of cardiotoxicity associated with chemotherapy and radiotherapy. The drugs commonly responsible for each toxicity are identified and clear advice is offered on monitoring techniques and treatment approaches. In addition, the issue of cardiotoxicity due to cancer treatment

Cardiotoxicity

Cardiotoxicity
  • Author : Wenyong Tan
  • Publisher : BoD – Books on Demand
  • Release : 14 November 2018
GET THIS BOOK Cardiotoxicity

Cardiotoxicity may be caused by radiotherapy and/or anticancer agents for many malignancies, adverse effects of some drugs in the context of medical intervention or heavy metal intake, especially during the anticancer therapy. This book intends to bring forward the recent development in toxicities from cancer treatment. It updates the possible mechanisms of cardiotoxicities of some anticancer agents and the suggested prevention and treatment strategies. This book contains many valuable contributions from the researchers in oncology and cardiology as well

Cancer and the Heart

Cancer and the Heart
  • Author : Michael S. Ewer,Edward T. H. Yeh, M.D.
  • Publisher : PMPH-USA
  • Release : 20 September 2021
GET THIS BOOK Cancer and the Heart

The book begins with the basic science behind the medical applications of the knowledge: cardiovascular biology, pathways, and their relationship to cancer treatment and principles of chemotherapy and immunotherapy. The second section consists of an overview and classification of anti-cancer drugs and a look at their cardiotoxicity. The third section looks at cardiac imaging in the cancer patient, including cardiac ultrasound, Doppler imaging, nuclear imaging, magnetic resonance imaging, and computed tomography in the cancer patient. In section four, management of

Cardiotoxicity

Cardiotoxicity
  • Author : Wenyong Tan
  • Publisher : Unknown
  • Release : 20 September 2021
GET THIS BOOK Cardiotoxicity

Cardiotoxicity may be caused by radiotherapy and/or anticancer agents for many malignancies, adverse effects of some drugs in the context of medical intervention or heavy metal intake, especially during the anticancer therapy. This book intends to bring forward the recent development in toxicities from cancer treatment. It updates the possible mechanisms of cardiotoxicities of some anticancer agents and the suggested prevention and treatment strategies. This book contains many valuable contributions from the researchers in oncology and cardiology as well

Enhancing Cardiomyocyte Survival in Drug Induced Cardiac Injury

Enhancing Cardiomyocyte Survival in Drug Induced Cardiac Injury
  • Author : Wael Maharsy
  • Publisher : Unknown
  • Release : 20 September 2021
GET THIS BOOK Enhancing Cardiomyocyte Survival in Drug Induced Cardiac Injury

Cardiotoxicity associated with many cancer drugs is a critical issue facing physicians these days and a huge hurdle that must be overcome for a side effects-free cancer therapy. Survival of cardiac myocytes is compromised upon the exposure to certain chemotherapeutic drugs. Unfortunately, the mechanisms implicated in cardiac toxicity and the pathways governing myocyte survival are poorly understood. The following thesis addresses the mechanisms underlying the cardiotoxicity of two anticancer drugs, doxorubicin (DOX) and Imatinib mesylate (Gleevec). Transcription factor GATA-4, has

Organ Directed Toxicities of Anticancer Drugs

Organ Directed Toxicities of Anticancer Drugs
  • Author : Miles P. Hacker,John S. Lazo,Thomas R. Tritton
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOK Organ Directed Toxicities of Anticancer Drugs

The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable

Cardiovascular Complications in Cancer Therapy

Cardiovascular Complications in Cancer Therapy
  • Author : Antonio Russo,Giuseppina Novo,Patrizio Lancellotti,Antonio Giordano,Fausto J. Pinto
  • Publisher : Springer
  • Release : 04 October 2018
GET THIS BOOK Cardiovascular Complications in Cancer Therapy

This proposed text is designed to provide a useful and comprehensive resource and state-of-the-art overview to readers about vascular damage potentially induced by antineoplastic drugs. Thanks to more and more effective antineoplastic treatments the survival of cancer patients is enormously increasing, but at the same time it is increasing the burden of related cardiovascular complications that affect morbidity and mortality. On this basis a new branch of cardiology has been developed, that is Cardio-Oncology. The aim is to prevent cardiovascular

Increased Arterial Stiffness and Reduced Cardiovagal Baroreflex Sensitivity with Anti Cancer Chemotherapy

Increased Arterial Stiffness and Reduced Cardiovagal Baroreflex Sensitivity with Anti Cancer Chemotherapy
  • Author : Jacob Nathaniel Frye
  • Publisher : Unknown
  • Release : 20 September 2021
GET THIS BOOK Increased Arterial Stiffness and Reduced Cardiovagal Baroreflex Sensitivity with Anti Cancer Chemotherapy

Background - Chemotherapy-induced left ventricular cardiotoxicity is associated with many cancer treatments; however, what is less known is how these treatments affect vascular health and autonomic control of blood pressure. Arterial stiffness and cardiovagal baroreflex sensitivity (BRS) are indicators of cardiovascular health and may provide insight into the adverse effects of anti-cancer chemotherapy. Therefore, the primary aims of the present study were to evaluate carotid artery stiffness and arterial BRS in cancer patients currently being treated with adjuvant chemotherapy. Methods